PAPER Jurcau MC, Jurcau A, Cristian A, Hogea VO, Diaconu RG, Nunkoo VS
SEARCH RESULTS
339720 RESULTS
PAPER Kawabata K, Poewe W
Letter to the editor: Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease.
Parkinsonism Relat Disord. 2024 Oct 9;:107163. PubMed.PAPER Mostile G, Terranova R, Carlentini G, Contrafatto F, Terravecchia C, Donzuso G, Sciacca G, Cicero CE, Luca A, Nicoletti A, Zappia M
Differentiating neurodegenerative diseases based on EEG complexity.
Sci Rep. 2024 Oct 17;14(1):24365. PubMed.PAPER Kovacs GG, Katsumata Y, Wu X, Aung KZ, Fardo DW, Forrest SL, Alzheimer's Disease Genetics Consortium, Nelson PT
Amyloid-β predominant Alzheimer's disease neuropathologic change.
Brain. 2024 Oct 17; PubMed.PAPER Prosser L, Sudre CH, Oxtoby NP, Young AL, Malone IB, Manning EN, Pemberton H, Walsh P, Barkhof F, Biessels GJ, Cash DM, Barnes J, Alzheimer's Disease Neuroimaging Initiative
Biomarker pathway heterogeneity of amyloid-positive individuals.
Alzheimers Dement. 2024 Oct 17; PubMed.PAPER Liu X, Jones PS, Pasternak M, Masellis M, Bouzigues A, Russell LL, Foster PH, Ferry-Bolder E, van Swieten J, Jiskoot L, Seelaar H, Sanchez-Valle R, Laforce R, Graff C, Galimberti D, Vandenberghe R, de Mendonça A, Tiraboschi P, Santana I, Gerhard A, Levin J, Sorbi S, Otto M, Pasquier F, Ducharme S, Butler C, Le Ber I, Finger E, Tartaglia MC, Synofzik M, Moreno F, Borroni B, Rohrer JD, Tsvetanov KA, Rowe JB, GENFI consortium
Frontoparietal network integrity supports cognitive function in pre-symptomatic frontotemporal dementia: Multimodal analysis of brain function, structure, and perfusion.
Alzheimers Dement. 2024 Oct 17; PubMed.PAPER Liu JJ, Yang JB, Wang Y, Hu XR, Wang YD, Nie LX, Wei F, Yu JD, Yao LW, Xu BL, Ma SC, Jin HY
Integrating network pharmacology and experimental validation to investigate the effects and mechanism of Renshen Shouwu decoction for ameliorating Alzheimer's disease.
Pharm Biol. 2024 Dec;62(1):767-780. Epub 2024 Oct 17 PubMed.PAPER Shome A, Jha KT, Chahat, Chawla V, Chawla PA
An Insight into Medicinal Chemistry and SAR Studies of Cholinesterase and BACE-1 Inhibitors for Alzheimer's Disease.
CNS Neurol Disord Drug Targets. 2024 Oct 16; PubMed.PAPER Schmidt AF, Davidson MH, Ditmarsch M, Kastelein JJ, Finan C
Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis.
Alzheimers Res Ther. 2024 Oct 16;16(1):228. PubMed.PAPER Choi JH, Lee J, Kang U, Chang H, Cho KH
Network dynamics-based subtyping of Alzheimer's disease with microglial genetic risk factors.
Alzheimers Res Ther. 2024 Oct 16;16(1):229. PubMed.PAPER Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, Wang C, Bao X, Finn MB, Hu H, Shchukina I, Kim MW, Yuede CM, Kipnis J, Artyomov MN, Ulrich JD, Holtzman DM
Author Correction: Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy.
Nature. 2024 Oct 16; PubMed. Corrected paper.PAPER Bartlett MJ, Erickson RP, Hutchinson EB, Witte RS, Witte MH
Brain Lymphatics: Rediscovery and New Insights into Lymphatic Involvement in Diseases of Human Brains.
Lymphology. 2024;57(1):27-33. PubMed.PAPER Lovering E, Kodishala C, George RJ, Kumar R, Crowson CS, Lennon RJ, Davis JM 3rd, Myasoedova E
The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis.
Semin Arthritis Rheum. 2024 Oct 11;69:152570. PubMed.PAPER Trisal A, Singh AK
Clinical Insights on Caloric Restriction Mimetics for Mitigating Brain Aging and Related Neurodegeneration.
Cell Mol Neurobiol. 2024 Oct 16;44(1):67. PubMed.PAPER Huang H, Ren Y, Wang J, Zhang Z, Zhou J, Chang S, Zhang Y, Xue J
Renal function and risk of dementia: a Mendelian randomization study.
Ren Fail. 2024 Dec;46(2):2411856. Epub 2024 Oct 16 PubMed.Current Filters
No filters selected